We are working from home under lockdown. Our team is continuously tracking the impact of COVID-19 across different industries and we will incorporate those insights in our reports. For any specific query, mail us at [email protected]
Infectious Disease Diagnostics Market | Forecasts up to 2025 | Covid-19 Impact Analysis
This report, from Stratview Research, studies the clinical diagnostics market - infectious diesease diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
New tests are always needed that can identify a specific pathogen or at a minimum, distinguish between bacterial and viral infections, and provide information on susceptibility to antimicrobial agents. Tests should be easy to use and provide a rapid result (ideally within an hour) to have a positive impact on care. The infectious diseases physician can serve as a bridge between the laboratory and the healthcare provider to ensure the proper use and interpretation of diagnostic testing. The expertise of the infectious diseases clinician becomes more important with the advent of newer, more complex tests. The availability of laboratory tests and POC (bedside) determines the improvements in clinical outcomes for patients, antimicrobial stewardship, detection and tracking of disease outbreaks, and investigation of unknown pathogens in all major markets.
The key players in the global market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland) while regional players in vary from Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Alere Inc., DiaSorin S.p.A., Quidel Corporation, besides the global players.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The global clinical diagnostics market (infectious disease diagnostics) is segmented into the following categories:
By Product & Service
By Testing Facility
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].